House Bill 190

Actions | Amendments
Last Action 04/18/24: signed by Governor (Acts Ch. 213)
Title AN ACT relating to pharmacy benefits.
Bill Documents Current/Final
Introduced
Fiscal Impact Statements Actuarial Analysis
Health Mandate
Local Mandate
Additional Fiscal Impact Statements Exist
Bill Request Number 898
Sponsor S. Sharp
Summary of Enacted Version Amends 2024 Ky. Acts. ch. 104, sec. 3 (2024 RS SB 188/GA, sec. 3) to define “national average drug acquisition cost,” to temporarily exempt retail chain pharmacies from minimum drug reimbursement requirement, and to make technical amendment; EFFECTIVE January 1, 2025.
Legislative History
Summary of Original Version Amend KRS 304.17A-164 to prohibit insurers, pharmacy benefit managers, and other pharmacy benefit administrators from requiring or incentivizing the use of a mail-order pharmaceutical distributor; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply provisions of amended KRS 304.17A-164 to limited health service benefit plans, including limited health service contracts, limited health service organizations, the state employee health plan, and postsecondary educational institution self-insured group health plans; repeal 304.38A-120, relating to assignment of certain benefits under limited health service organization plans, to consolidate like provisions; make technical corrections; EFFECTIVE January 1, 2025.
Index Headings of Original Version Local Mandate - Prescription drugs, distribution, requirements
Drugs and Medicines - Prescription drugs, distribution, insurance practices
Education, Higher - Health plan, prescriptions drugs, distribution, requirements
Effective Dates, Delayed - Prescription drugs, distribution, insurance practices, January 1, 2025
Insurance, Health - Prescription drugs, distribution, requirements
Pharmacists - Prescription drugs, distribution, insurance practices
State Employees - Health plan, prescription drugs, distribution, requirements
Technical Corrections - Prescription drugs, distribution, insurance practices
Health Benefit Mandate - Prescription drugs, distribution, requirements
Actuarial Analysis - Prescription drugs, distribution, insurance practices
Jump to Proposed Amendments House Committee Substitute 1 with Fiscal Impact Statements
Senate Committee Substitute 1
Votes Vote History

Actions

Top | Amendments
01/08/24
  • introduced in House
  • to Committee on Committees (H)
02/15/24
  • to Health Services (H)
03/07/24
  • reported favorably, 1st reading, to Calendar with Committee Substitute (1)
03/08/24
  • 2nd reading, to Rules
  • posted for passage in the Regular Orders of the Day for Monday, March 11, 2024
03/12/24
  • 3rd reading, passed 96-0 with Committee Substitute (1)
03/13/24
  • received in Senate
  • to Committee on Committees (S)
03/28/24
  • taken from Committee on Committees (S)
  • 1st reading
  • returned to Committee on Committees (S)
04/12/24
  • to Banking & Insurance (S)
  • taken from Banking & Insurance (S)
  • 2nd reading
  • returned to Banking & Insurance (S)
04/15/24
  • reported favorably, to Rules with Committee Substitute (1) as a consent bill
  • posted for passage in the Consent Orders of the Day for Monday, April 15, 2024
  • 3rd reading, passed 38-0 with Committee Substitute (1)
  • received in House
  • to Rules (H)
  • posted for passage for concurrence in Senate Committee Substitute (1)
  • House concurred in Senate amendment Committee Substitute (1)
  • passed 92-0
  • enrolled, signed by Speaker of the House
  • enrolled, signed by President of the Senate
  • delivered to Governor
04/18/24
  • signed by Governor (Acts Ch. 213)

Proposed Amendments

Top | Actions
Amendment House Committee Substitute 1
Fiscal Impact Statements Actuarial Analysis to House Committee Substitute 1
Health Mandate to House Committee Substitute 1
Local Mandate to House Committee Substitute 1
Summary Retain original provisions, except amend definition of "insurer" to make technical amendment; add definition of "mail-order pharmaceutical distributor"; delete prohibition on requiring or incentivizing use of a mail-order pharmaceutical distributor; prohibit imposing greater or more restrictive requirements for use of a retail pharmacy to access a drug in certain circumstances.
Index Headings Local Mandate - Prescription drugs, distribution, requirements
Actuarial Analysis - Prescription drugs, distribution, insurance practices
Health Benefit Mandate - Prescription drugs, distribution, insurance practices
Drugs and Medicines - Prescription drugs, distribution, insurance practices
Insurance, Health - Prescription drugs, distribution, requirements
Pharmacists - Prescription drugs, distribution, insurance practices

Amendment Senate Committee Substitute 1
Summary Delete original provisions; amend 2024 Ky. Acts. ch. 104, sec. 3 (2024 RS SB 188/GA, sec. 3) to define "national average drug acquisition cost"; temporarily exempt retail chain pharmacies from minimum drug reimbursement requirement; make technical amendment; EFFECTIVE January 1, 2025.
Index Headings Drugs and Medicines - Minimum reimbursement, prescription drugs and other services
Effective Dates, Delayed - Pharmacy provider contracts, minimum reimbursement, January 1, 2025
Insurance, Health - Provider contracts, minimum reimbursement, prescription drugs and other services
Pharmacists - Minimum reimbursement, prescription drugs and other services
Actuarial Analysis - Minimum reimbursement, prescription drugs and other services
Health Benefit Mandate - Minimum reimbursement, prescription drugs and other services
Local Mandate - Minimum reimbursement, prescription drugs and other services
Technical Corrections - HB 190/SCS 1

Last updated: 6/13/2024 7:47 AM (EDT)